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Abstract
Hypoxia ischemia (HI)-related brain injury is the major cause of long-term morbidity in neonates. One characteristic hallmark
of neonatal HI is the development of reactive astrogliosis in the hippocampus. However, the impact of reactive astrogliosis
in hippocampal damage after neonatal HI is not fully understood. In the current study, we investigated the role of Na+/H+
exchanger isoform 1 (NHE1) protein in mouse reactive hippocampal astrocyte function in an in vitro ischemia model
(oxygen/glucose deprivation and reoxygenation, OGD/REOX). 2 h OGD significantly increased NHE1 protein expression and
NHE1-mediated H+ efflux in hippocampal astrocytes. NHE1 activity remained stimulated during 1–5 h REOX and returned to
the basal level at 24 h REOX. NHE1 activation in hippocampal astrocytes resulted in intracellular Na+ and Ca2+ overload. The
latter was mediated by reversal of Na+/Ca2+ exchange. Hippocampal astrocytes also exhibited a robust release of
gliotransmitters (glutamate and pro-inflammatory cytokines IL-6 and TNFa) during 1–24 h REOX. Interestingly, inhibition of
NHE1 activity with its potent inhibitor HOE 642 not only reduced Na+ overload but also gliotransmitter release from
hippocampal astrocytes. The noncompetitive excitatory amino acid transporter inhibitor TBOA showed a similar effect on
blocking the glutamate release. Taken together, we concluded that NHE1 plays an essential role in maintaining H+
homeostasis in hippocampal astrocytes. Over-stimulation of NHE1 activity following in vitro ischemia disrupts Na+ and Ca2+
homeostasis, which reduces Na+-dependent glutamate uptake and promotes release of glutamate and cytokines from
reactive astrocytes. Therefore, blocking sustained NHE1 activation in reactive astrocytes may provide neuroprotection
following HI.
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Introduction
Hippocampal astrocytes are in intimate physical relationship
with neurons. Each hippocampal astrocyte is in contact with
several hundred dendrites from multiple neurons and envelope
hundreds of thousands of synapses [1]. Thus, astrocytes play a
direct role in hippocampal neuronal function by maintaining the
ionic and neurotransmitter homeostasis of the synaptic interstitial
space that is critical to synaptic transmission. Astrocytes can alter
neuronal excitability through Ca2+ signaling or by release of
synaptically active ‘‘gliotransmitters’’ (glutamate, ATP, and
adenosine) [2]. Astrocytes can prevent neuronal energy failure
by providing ATP during and after ischemia. In addition,
glutamate uptake by glutamate transporters in astrocytes may
decrease the detrimental effects of excessive glutamate release after
ischemia [3]. Hippocampal astrocytes respond to neonatal
hypoxia ischemia (HI) by developing reactive astrogliosis, which
is characterized by up-regulation of glial fibrillary acid protein
(GFAP) expression, astrocyte hypertrophy, and astrocyte prolifer-
ation [3,4]. However, the significance of reactive astrogliosis and
its contribution to hippocampal damage after HI in neonates is
unknown.
Na+/H+ exchanger isoform 1 (NHE1) is a membrane protein
that functions to regulate intracellular pH (pHi) by extrusion of
one H+ in exchange for one Na+ [5]. Thus, acidosis following HI
may trigger increased expression and activation of NHE1 to
correct acidosis. We recently reported that expression of NHE1
protein was dramatically increased in hippocampal GFAP-positive
reactive astrocytes at 72 h following HI in a neonatal mouse model
[6]. We found that inhibition of NHE1 with its selective and
potent inhibitor HOE 642 decreased CA1 pyramidal neuronal
damage and improved motor and spatial learning [6]. We
speculate that enhanced NHE1 activity in reactive astrocytes is
detrimental and inhibition of NHE1 may offer neuroprotection in
part via blocking NHE1 in reactive astrocytes. Here we report that
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NHE1 protein expression was up-regulated in hippocampal
reactive astrocytes after in vitro ischemia (oxygen and glucose
deprivation and reoxygenation, OGD/REOX). We also detected
concurrent elevation of NHE1 activity, increased intracellular
sodium concentration ([Na+]i) and intracellular calcium concen-
tration ([Ca2+]i), and release of glutamate and cytokines from
hippocampal astrocytes following OGD/REOX. Interestingly,
inhibition of NHE1 activity significantly reduced all of these
events. Therefore, we concluded that over-stimulation of NHE1
promotes gliotransmitter and cytokine release from reactive
astrocytes, which can subsequently contribute to hippocampal
neuronal damage under hypoxic and ischemic conditions.
Experimental Procedures
Materials
Hanks balanced salt solution (HBSS) and L-glutamine were
from Mediatech Cellgro (Manassas, VA). BCECF-AM, fura2-AM,
Sodium Green-AM, and the AmplexH Red Glutamic Acid/
Glutamate Oxidase kit were from Invitrogen (Carlsbad, CA).
Gramicidin, ionomycin, nigericin, calcein-AM, propidium iodide
(PI) and L-leucine methyl ester were purchased from Sigma (St.
Louis, MO). HOE 642 was a kind gift from Aventis Pharma
(Frankfurt, Germany). DL-threo-b-benzyloxyaspartate (TBOA)
was from Tocris (Ellisville, MO). Fetal bovine serum (FBS) was
obtained from Valley Biomedical (Winchester, VA). Rabbit anti-
NHE1 polyclonal antibody was purchased from Abcam (Cam-
bridge, MA). ELISA kits for the cytokines IL-1, IL-6, and TNF-a
were from R & D (Minneapolis, MN). Mouse anti-glial fibrillary
acidic protein (GFAP) monoclonal antibody was from Cell
Signaling (Danvers, MA). Monoclonal antibody cocktail against
GFAP derived from the Bigner-Eng clones MAb1B4, MAb2E1
and MAb4A11 was from Convance (Princeton, NJ). Mouse anti-a
tubulin monoclonal antibody was from Promega (Madison, WI).
m.
Primary Hippocampal Astrocyte Culture
This study was carried out in strict accordance with the
recommendation in the Guide for the Care and Use of laboratory
Animals of the National Institute of Health. The protocol was
approved by the University of Wisconsin-Madison, Institutional
Animal Care and Use Committee (Protocol G000614). Harvesting
of tissue for culture was done under isoflurane anesthesia and all
efforts were made to minimize pain. Dissociated hippocampal
astrocyte cultures were prepared from the hippocampus of 3–4
day old mice as described before [7] with minor modifications.
Hippocampal cortices were removed from the mice, minced, and
rinsed in ice-cold HBSS. The cortices were then incubated in
trypsin solution (0.25 mg/ml in HBSS) for 20 min at 37uC. Cells
were then dissociated by gentle trituration in culture medium
containing EMEM supplemented with 2 mM L-glutamine, 10%
FBS, 100 IU/ml penicillin and 0.1-mg/ml streptomycin. Cells
were then passed through a 40 mm cell strainer, centrifuged, and
resuspended in culture media. Viable cells (46104 cells/6 well,
16103 cells/24 well) were either plated on glass coverslips
(22622 mm) coated with collagen type 1 placed in petri dishes,
six well plastic culture plates, 24-well culture plates or 35 mm glass
bottomed culture dishes (15 mm). Cultures were maintained in a
5% CO2 atmosphere at 37uC. To obtain morphologically
differentiated astrocytes, confluent cultures (7 days in culture,
DIV 7) were treated with EMEM containing 0.25 mM dibutyryl
cyclic AMP (dBcAMP) to induce differentiation.
In some studies, three-day old astrocyte cultures were supple-
mented with 5 mM L-leucine methyl ester (LME) for 10 days to
remove possible microglial contamination in the astrocyte cultures.
LME is a microglial cytotoxic agent that has been used extensively
as a method to eliminate proliferating microglia [8,9]. After
incubation, LME-treated cultures were subjected to a shaking
protocol (300 RPM for 1 h) to remove possible contaminating
microglia. Experiments were routinely performed in cultures 10–
12 days old.
OGD/REOX
Hippocampal astrocyte cultures were rinsed with an isotonic
OGD solution (pH 7.4) containing (in mM): 0 glucose, 21
NaHCO3, 120 NaCl, 5.36 KCl, 0.33 Na2HPO4, 0.44 KH2PO4,
1.27 CaCl2, and 0.81 MgSO4. The cells were incubated in the
OGD solution for 2 h in a hypoxic incubator (model 3130,
Thermo Forma; Asheville NC) containing 94% N2, 1% O2, and
5% CO2. Normoxic control cells were incubated for 2 h in 5%
CO2 and atmospheric air in a buffer identical to the OGD solution
except for the addition of 5.5 mM glucose. For REOX, the OGD
solution was replaced with EMEM containing 10% FBS and
incubation at 37uC in 5% CO2 and atmospheric air.
pHi Measurement
pHi measurement and prepulse treatment were performed as
described previously [10]. Briefly, hippocampal astrocyte cultures
grown on coverslips were incubated with 0.75–1.5 mM BCECF-
AM at 37uC for 30 min. The coverslips were placed in a
temperature controlled (37uC) open-bath imaging chamber
(Model RC24, Warner Instruments, Hamden, CT) containing
HCO3
–free HEPES-MEM solution (mM, pH 7.4): 140 NaCl, 5.36
KCl, 0.81 MgSO4, 1.27 CaCl2, 0.44 KH2PO4, 0.33 Na2HPO4,
5.55 glucose and 20 HEPES. The chamber was mounted on the
stage of the Nikon TI Eclipse inverted epifluorescence microscope
and the cells visualized with a 40X objective. The cells were
excited every 10–30 s at 440 and 490 nm, and the emission
fluorescence at 535 nm recorded. Images were collected using a
Princeton Instruments MicroMax CCD camera and analyzed with
MetaFluor (Molecular Devices, Sunnyvale, CA) image-processing
software. The ratio of the background-corrected fluorescence
emissions (F490/F440) was calibrated using the high K+/nigericin
technique [11].
For the pre-pulse treatment, cells were subjected to an acid load
by a transient application (2.5 min) of a 30 mM NH4
+/NH3
solution as described previously [10]. NH4
+/NH3 solutions were
prepared by replacing 30 mM NaCl in the HCO3
2 -free, HEPES-
buffered solution with an equimolar concentration of NH4Cl. pHi
recovery rate during the first min after NH4
+/NH3 prepulse was
determined from the slope of a fitted linear regression at, pH 6.5
[12].
[Ca2+]i Determination
Hippocampal astrocytes grown on coverslips were incubated
with 5 mM fura-2AM for 2 h at 37uC. The cells were rinsed with
PBS and quickly (,2 min) placed on an open-bath imaging
chamber and superfused (1 mL/min) with HCO3-MEM at 37uC.
Using a TI Eclipse inverted epifluorescence microscope (40X
objective), cells were excited every 10 sec at 340 and 380 nm, and
the emission fluorescence at 510 nm was recorded. Images were
collected and analyzed with the MetaFluor image-processing
software. At the end of each experiment, the cells were exposed to
1 mM MnCl2 and 5 mM Br-A23187 in Ca2+-free HEPES-MEM.
The Ca2+-insensitive fluorescence was subtracted from each
wavelength before calculations [13]. The MnCl2-corrected 340/
380 emission ratios were converted to [Ca2+]i as described
previously [13].
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Measurement of [Na+]i
[Na+]i was determined using the fluorprobe sodium green-AM.
Hippocampal astrocytes grown on glass-bottomed culture dishes
(In Vitro Scientific, Sunnyvale, CA) were loaded with 15 mM
sodium green-AM at 37uC for 2 h under normoxia, OGD, or
REOX conditions. For OGD treatment, cells were incubated at
37uC with 200 ml OGD buffer for 2 h in a hypoxic incubator
containing 94% N2, 1% O2, and 5% CO2. Normoxic control cells
were incubated for 2 h in 5% CO2 and atmospheric air in a buffer
(200 ml) identical to the OGD solution except for the addition of
5.5 mM glucose. Cells were then washed with HEPES-MEM and
placed in a stage top incubator (Tokai Hit, Shizuoka-ken, Japan) at
37uC on the stage of Nikon A1 confocal microscope equipped with
a perfect focus system and images collected every 20 sec (488 nm
excitation, 525 emission) using a 60X objective. After a one min
baseline collection, cells were subjected to an in-situ calibration
using the ionophores gramicidin and monensin. Absolute [Na+]i
was determined as described before [14].
Immunofluorescence Staining
Hippocampal astrocytes grown on coverslips were fixed in 4%
paraformaldehyde in phosphate-buffered saline (PBS) for 15 min.
After rinsing, cells were incubated with a blocking solution for
20 min followed by application of rabbit anti-NHE1 polyclonal
antibody (1:100) and mouse anti-GFAP monoclonal antibody
(1:500) diluted in the blocking buffer at 4uC overnight. After
rinsing in PBS, cells were incubated with goat anti-mouse
secondary antibody IgG (H+L) conjugated to Alexa FluorH 488
(1:200 dilution) and goat anti-rabbit secondary antibody IgG
(H+L) conjugated to Alexa FluorH 546 (1:200 dilution) for 1 h at
37uC. Fluorescence images were captured with a Leica DMIRE2
inverted confocal laser-scanning microscope (40X objective).
Immunoblotting
Hippocampal astrocyte cells were scraped from the flasks and
lysed by 30 s sonication at 4uC in PBS (pH 7.4, 2 mM EDTA and
protease inhibitors) [15]. Protein content was determined by the
bicinchoninic acid method. Protein samples (60 mg/lane) and pre-
stained molecular mass markers (Bio-Rad, Hercules, CA) were
denatured in sodium dodecyl sulfate 5X sample buffer and then
electrophoretically separated on 8% sodium dodecyl sulfate gels.
After transferring to a nitrocellulose membrane, the blots were
incubated in 5% nonfat dry milk in Tris-buffered saline for 2 h at
room temperature, and then incubated with rabbit anti-NHE1
polyclonal antibody (1:800) and mouse anti-GFAP monoclonal
antibody (1:1000) overnight at 4uC. After rinsing, the blots were
incubated with horseradish peroxidase-conjugated secondary IgG
at room temperature for 1.5 h. Bound antibody was visualized
using an enhanced chemiluminescence assay (Amersham Corp.,
Burlington, MA).
Glutamate Release Measurement
Glutamate released in cell culture medium was determined
using an amplexH red glutamic acid/glutamate oxidase assay kit as
per the manufacturer’s instructions. Hippocampal astrocytes
(100,000 cells) grown on 20620 mm coverslips in six-well plates
were incubated with 200 ml OGD buffer for 2 h in a hypoxic
incubator containing 94% N2, 1% O2, and 5% CO2. Normoxic
control cells were incubated for 2 h in 5% CO2 and atmospheric
air in the control buffer (200 ml). For medium sample collection at
1, 5 or 24 h REOX, 200 ml medium was collected and replaced
with fresh medium. At the end of an experiment, 1 ml of medium
was used for glutamate release measurement. Cells on the
coverslips were lysed and protein content in each lysate was
determined by the bicinchoninic acid method (BCA). The
fluorescence (571 nm excitation/585 nm emission) of each medi-
um sample was determined using a Gemini EM fluorescence
microplate reader (Molecular Devices, Sunnyvale, CA). Glutamate
concentration in medium sample (mM) was determined using a
nine-point standard curve and all analyses were done in duplicate.
The glutamate release in each sample was expressed as pg/mg
lysate protein.
Pro-inflammatory Cytokine Measurement
Hippocampal astrocytes cultured in six-well plates in medium
(0.5 ml) were subjected to 2 h OGD plus 1, 5, or 24 h REOX. For
analysis of TNF-a, IL-1b and IL-6 release in the medium, DuoSet
cytokine ELISA kits (R&D systems, Minneapolis, MN) was used as
per the instructions of the manufacturer. After removing the
culture media for cytokine determination, the cells in each well
were lysed and the protein concentration determined using the
BCA method. 96-well plates were coated overnight with the
respective diluted capture antibodies in 100 ml PBS/well (contain-
ing TNF-a, 14.4 mg; IL-1b, 72.0 mg; IL-6, 36.0 mg). After three
washings with wash buffer (0.05% tween 20 in PBS, pH 7.2),
plates were blocked (300 ml 1% BSA in PBS) for 1 h. Cytokine
standards (100 mL) or culture medium samples (, 0.3 mg protein)
were added and incubated at room temperature for 2 h. After the
incubation, 100 mL of the biotinylated detection antibodies (TNF-
a, 200 ng; IL-1b, 600 ng; or IL-6, 200 ng) were added to each
well and incubated for 2 h. 100 mL of the diluted streptavidin-
HRP (1:200) antibody was added and plates were allowed to
incubate for 20 min at room temperature. Following washing,
chromogen was added and the reaction was stopped with a stop
solution. The optical density of each well at 450 nm was
determined immediately using a microplate reader (Molecular
Devices, Sunnyvale, CA). A seven-point standard curve was
generated with each run using supplied standards for each set of
samples assayed. TNF-a, IL-1b or IL-6 was calculated with the
standard curve and expressed as pg/mg protein. Based on the
standard curve, the lowest detectable limits for TNF-a, IL-1b, or
IL-6 were 31.25 pg/ml, 15.62 pg/ml, and 15.62 pg/ml,
respectively.
Cell Viability Assay
Hippocampal astrocytes grown on 24 well plates were subjected
either to normoxia, 2 h OGD plus 5 h REOX, 5 h REOX
+1 mMHOE 642, 24 h REOX or 24 h REOX +1 mMHOE 642.
Cells were rinsed with HEPES-MEM and incubated for 30 min
with 0.5 mM calcein-AM and 2 mg/ml PI in HEPES-MEM.
Calcein (488 nm excitation, 525 emission) or PI (543 nm
excitation, 610 emission) signals were obtained with a Nikon A1
confocal microscope under a 10X objective (Nikon Instruments,
Melville, NY). Cell death was calculated by the ratio of PI positive
cells to the number of calcein positive cells plus PI positive cells.
The percent death calculated from each of 6 wells for per
experimental condition was expressed as mean 6 SEM.
Statistical Analysis
Values are expressed as the mean 6 SEM. Either a t-test or the
Mann-Whitney rank sum test was used to compare the vehicle
control and the drug-treated groups. ANOVA with Bonferroni
post-test was used in the case of multiple comparisons. P-values
smaller than or equal to 0.05 were considered statistically
significant. Statistical analysis was performed using Sigmaplot
(SPSS, Inc., Chicago, IL).
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Results
Up-regulation of NHE1 Protein Expression in
Hippocampal Astrocytes in in vitro Ischemia Model
Basal level of NHE1 protein expression was detected in cultured
hippocampal astrocytes under normoxic conditions (Figure 1 A,
arrow). NHE1 protein was expressed in all GFAP-positive
astrocytes. At 2 h OGD as well as at 2 h OGD/5 h REOX,
astrocytes exhibited classical reactive astrocytes morphology:
retracted primary processes, hypertrophy of the soma and
processes, and increased expression of GFAP. Interestingly,
NHE1 immuoreactivity in hippocampal reactive astrocytes was
enhanced at 2 h OGD/5 h REOX (Figure 1 A, arrow). We
further characterized the expression of GFAP and NHE1
following OGD by immunoblotting. Following 2 h OGD, GFAP
expression was increased by ,2.5-fold (Figure 1 B). 2 h OGD/
5 h REOX resulted in a further increase in GFAP expression to ,
7.5-fold of normoxic levels. Similar to the immunohistochemical
staining data, GFAP expression returned toward normoxic levels
after 24 h REOX. In the case of NHE1 expression, there was a
13-fold increase in NHE1 expression at the end of OGD, followed
by an elevation to 30-fold of normoxic levels at 5 REOX (Figure 1
C, bottom panel). At 24 h REOX, NHE1 expression nearly
returned to normoxic levels. These results demonstrate that
OGD/REOX triggered transformation of hippocampal astrocytes
to reactive astrocytes. Expression of NHE1 protein was signifi-
cantly increased in reactive astrocytes.
Increased NHE1 Activity in Hippocampal Astrocytes
Following OGD/REOX
We then investigated changes of NHE1 activity by measuring
basal pHi and pHi recovery rate in these astrocytes in response to
an NH3/NH4
+ prepulse-induced acidification. As shown in
Figure 2 A (left panel), when normoxic control astrocytes were
exposed to 30 mM NH3/NH4
+, pHi rose rapidly as NH3 diffused
into the cell and combined with H+ to form NH4
+ (a–b) and then
declined slowly over 2.5 min (b–c). Returning cells to standard
HCO3
–free HEPES-MEM solution caused pHi to decrease due to
the rapid efflux of NH3 from cells and trapping H
+ inside the cells
(c–d). Normoxic control cells were able to restore pHi to their
basal levels over time (Figure 2 A, d–e). However, when NHE1
protein was inhibited with its potent inhibitor HOE 642 (1 mM),
cells nearly failed to recover the pHi. This suggests that under
normal HCO3
–free conditions, hippocampal astrocytes largely
depend upon NHE1 activity to regulate pHi.
The OGD-treated reactive astrocytes exhibited a more acidic
basal pHi compared to control cells (6.7460.03 vs. 6.9560.02 pH
units, p,0.05, Figure 2 A, B). A faster pHi recovery with a
steeper slope was detected following the NH3/NH4
+ prepulse-
induced acidification in the OGD-treated reactive astrocytes
(Figure 2 A, right panel and Figure 2 B, right panel). This
elevated H+ extrusion in the OGD-treated cells was mediated by
NHE1 activity because blocking NHE1 activity with HOE 642
nearly abolished the pHi recovery (Figure 2A, right panel).
Moreover, hippocampal astrocytes maintained a relatively stable
pHi during 1–24 h REOX (Figure 2 B, left panel). At 5 h
REOX, the pHi was reduced from 6.9660.02 to 6.8660.04. By
24 h REOX, the astrocytes became slightly alkaline (7.0260.03).
Interestingly, inhibition of NHE1 with HOE 642 acidified
astrocyte pHi under both normoxic conditions and 2 h OGD or
1–24 h REOX (Figure 2 B, left panel). The strongest effect of
NHE1 blockade occurred at 2 h OGD. On the other hand, 2 h
OGD increased pHi regulation rate from a basal level of
0.3260.03 to 0.5360.06 pH unit/min (p,0.05). This elevation
Figure 1. Up-regulation of NHE1 protein expression in reactive
hippocampal astrocytes. A. Expression of NHE1 protein in
hippocampal astrocytes. Immunofluorescence signals of NHE1 and
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on H+ extrusion was sustained through 1–5 h REOX. At 24 h
REOX, the pHi regulation rate returned to the basal level. In the
presence of NHE1 inhibitor HOE 642, hippocampal astrocytes
failed to regulate pHi under all conditions (, 0.05 pH unit/min).
This suggests that the OGD/REOX caused a sustained increase in
H+ efflux, which is largely via stimulation of NHE1 activity. This
view was further demonstrated in Figure 2 C. HOE 642-sensitive
pHi recovery rate (NHE1-mediated) was increased at 1–5 h
REOX. At 24 h REOX, NHE1-mediated pHi regulation rate
returned to control values. These data suggest that NHE1 plays an
important role in maintaining pHi in hippocampal astrocytes and
its stimulation contributes to H+ extrusion and intracellular
alkalization after OGD/REOX.
Changes of [Na+]i and [Ca
2+]i in Hippocampal Astrocytes
Following OGD/REOX
We investigated whether overstimulation of NHE1 results in
Na+ and Ca2+ overload in reactive astrocytes after OGD/REOX.
First, we determined [Na+]i in hippocampal astrocytes during
OGD/REOX. The resting level of [Na+]i in hippocampal
astrocytes was 10.062.6 mM and did not change significantly
when NHE1 was inhibited (12.160.1 mM). Following 2 h OGD,
[Na+]i was not different from normoxia (Figure 3 A). Upon
REOX, [Na+]i increased to 22.161.8 mM at 1 h REOX and
34.561.1 mM by 5 h of REOX (p,0.05, Figure 3 A). At 24 h of
REOX, [Na+]i decreased by 45% but remained significantly
elevated compared to normoxic control (18.961.4 mM). In
contrast, inhibition of NHE1 activity with 1 mM HOE 642
reduced [Na+]i by , 75% (13.361.8 vs. 22.161.8 mM) at 1 h
REOX and , 50% (22.562 mM vs. 34.161 mM) at 5 h REOX
(Figure 3 A). After 24 h REOX, [Na+]i in the HOE-treated cells
returned to normoxic levels (12.161.8 mM). Taken together,
these data indicate that activation of NHE1 activity led to
sustained Na+i overload in reactive astrocytes after OGD/REOX.
We further investigated whether Na+i overload could induce an
elevation in [Ca2+]i via reversal of Na
+/Ca2+ exchanger (NCXrev)
in hippocampal astrocytes following OGD/REOX. Basal [Ca2+]i
in hippocampal astrocytes was 44.2612.1 nM and was not
affected by 1 mM of HOE 642 (65.2621.2 nM). [Ca2+]i remained
unchanged following 2 h OGD and at1 h REOX (Figure 3 B).
However, at 3 h REOX, [Ca2+]i in astrocytes increased signifi-
cantly (416.7643.9 nM), and remained elevated at 5 h of REOX
(307.4610.6 nM, p,0.05, Figure 3 B). Interestingly, in hippo-
campal astrocytes treated with 1 mM HOE 642 the increase in
[Ca2+]i was much less at either 3 h REOX (155.2628.6 nM) or at
5 h REOX (166.364.5 nM, Figure 3 B). This implies that the
rise in [Ca2+]i may result from increased NCXrev subsequent to
Na+i overload (although we did not determine [Na
+]i at 3 h
REOX, it remained elevated at 5 h REOX and could stimulate
NCXrev). To test this possibility, we examined whether SEA 0400
(1 mM), a potent inhibitor of NCXrev, could block the increases in
Ca2+ after OGD/REOX in hippocampal astrocytes. As shown in
Figure 3 B, inhibition of NCXrev with SEA 0400 abolished the
OGD/REOX-mediated rise in [Ca2+]i. Interestingly, SEA 0400
effects are similar to the inhibition of NHE1 by HOE 642. These
data illustrate that NHE1 activation in hippocampal astrocytes can
couple with reverse mode operation of NCXrev and result in Ca
2+
elevation subsequent to intracellular Na+ overload.
GFAP were shown under normoxia control or OGD (2 h) plus 0 h, 5 h, or
24 h REOX. Green: GFAP, red: NHE1 (arrows), blue: To-pro-3 nuclear
staining. Scale Bar: 20 mm. B, C. Quantification of GFAP (B) and NHE1
protein (C) expression with immunoblotting. Hippocampal astrocytes
were subjected to 2 h OGD followed by 5 or 24 h REOX. Total pixel
density in each protein band (minus background) was calculated using
Image J. Data are expressed as the ratio of either GFAP or NHE1 to the
corresponding a-tubulin band and normalized to the control. Data are
mean 6 SEM (n= 4). *p,0.05 vs. normoxia.
doi:10.1371/journal.pone.0084294.g001
Figure 2. Increased NHE1 activity in hippocampal astrocytes
following OGD/REOX. A. pHi changes were determined by BCECF-
AM dye in astrocytes subjected to NH4
+/NH3 prepulse-mediated acid-
loading. Either normoxic astrocytes (left panel) or astrocytes at 2 h OGD
(right panel) were exposed to 30 mM NH4Cl3 (a–c), then returned to
standard HCO3
–free HEPES-MEM solution (c–e). After an initial
acidification, pHi recovery followed (d–e). The pH recovery rates were
determined at , 6.5 to normalize for the allosteric regulation of H+ on
NHE1 activity. A slope of the pH i changes following the prepulse was
calculated as pHi recovery rate (solid or dashed line). For HOE 642
treatment, the drug was present throughout the experiment. B. pHi
(left panel) and pHi recovery rates (right panel) were summarized under
normoxic control, 2 h OGD, or 1, 5, or 24 h REOX conditions. C.
Summary data of NHE1-mediated recovery rates under normoxic and
OGD/REOX conditions. The values of ,20 cells from each coverslip/
culture were averaged. The n values were the number of cultures under
each condition and indicated as normoxia (9), normoxia+HOE 642 (6), 0
REOX (5), 0 REOX+HOE 642 (4), 1 h REOX (3), 1 h REOX+HOE 642 (4), 5 h
REOX (5), 5 h REOX+HOE 642 (4), 24 h REOX (4) and 24 h REOX+HOE
642 (3). Data are expressed as mean 6 SEM. *p,0.05 vs. corresponding
untreated. # p,0.05 vs. corresponding untreated.
doi:10.1371/journal.pone.0084294.g002
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Roles of NHE1 in Glutamate and Cytokine Release from
Hippocampal Astrocytes following OGD/REOX
We speculate that overstimulation of NHE1 activity may affect
glutamate release and/or uptake via disruption of Na+ and H+
homeostasis. To test this, we measured glutamate release from
astrocytes after OGD/REOX. No detectable glutamate release
was found in medium of the normoxic hippocampal astrocyte
cultures (Figure 4 A). Following 2 h of OGD or 1 h REOX, low
levels of glutamate (0.0460.04 pmol/mg protein) were released
from hippocampal astrocytes. These data suggest that hippocam-
pal astrocytes release minimal amount of glutamate after OGD or
early REOX. In contrast, following 5 h REOX, glutamate release
from hippocampal astrocytes increased dramatically to
9.661.7 pmol/mg protein (Figure 4 A). At 24 h REOX,
although the glutamate levels in the media were reduced, they
remained elevated compared to normoxic levels (5.961.4 pmol/
mg protein, Figure 4 A). Inhibition of NHE1 activity in
hippocampal astrocytes with 1 mM HOE 642 had no effect on
the release of glutamate at 2 h OGD or 1 h REOX (p.0.05,
Figure 4 A). However, blocking NHE1 activity decreased the
glutamate release by , 50% at 5 h and , 35% at 24 h REOX
(Figure 4 A). It is unclear how blocking NHE1 activity can reduce
glutamate release from astrocytes following OGD/REOX.
To test whether glutamate release was mediated via reversal of
Na+-dependent excitatory amino acid transporter (EAATs) subse-
quent to increases in Na+i, we investigated if the competitive non-
transportable EAAT blocker TBOA can block the glutamate
release. 100 mM TBOA had no effects on the glutamate release at
2 h OGD or 1 h REOX (p.0.05, Figure 4 A). The lack of effect
on glutamate release further implies that little glutamate is released
during this initial OGD/REOX period. However, TBOA nearly
abolished the glutamate efflux (,95%) at 5 h REOX and reduced
the glutamate release by 80% at 24 h REOX. These data further
suggest that glutamate release during REOX was primarily
through reversal of EAATs. To further confirm glutamate release
through reversal of the transporter, we calculated the reversal
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Where R is the gas constant, T is temperature, F is the Faraday
constant, and Vrev is the reversal potential. The values for [Na]o,
[Na]i, [H]o, [H]i and [K]o are known, the [Glu]o were estimated
to be 0.01 mM at baseline, 0.1 mM at 5 h REOX and 0.05 mM at
24 h REOX. Assuming a value for [Glu]i of 5 mM and [K]i of
70 mM, then Vrev=253.6 mV. Cultured cortical astrocytes have
a large range of resting plasma membrane potentials, but average
, 260 mV when measured either by whole cell or perforated
electrophysiological recordings [16]. Thus, under culture condi-
tions, when the [Glu]o was very low, the glutamate transporters
were near their reversal potentials and little or no flux through the
transporter would be expected. In contrast, because of the
stoichiometry of three Na+/glutamate anion transporter, the
reversal potential was sensitive to changes of [Na]i (Figure 4 A
inset). At 5 h REOX with a [Na]i of 34.5 mM and [K]i of
45.5 mM, the reversal potential dropped to 278.2 mV and efflux
of glutamate through the transporters would be favored. At 24 h
REOX, when [Na]i decreased to 19 mM the reversal potential fell
to 259.6 mV, making glutamate release less likely.
Next, we accessed the release of pro-inflammatory cytokines IL-
1b, IL-6 and TNF-a from hippocampal astrocytes following
OGD/REOX. Neither OGD nor 1 h REOX resulted in
significant release of the cytokines (Figure 4 B–D). However,
after 5 h REOX, we detected a transient increase in the release of
IL-1b, IL-6 and TNF-a by 6-fold, 33-fold and 33-fold, respec-
tively. Similar to the glutamate release, the release of the
proinflammatory cytokines from hippocampal astrocytes returned
to control levels by 24 h REOX (Figure 4 B–C). Interestingly, in
the presence of the NHE1 inhibitor HOE 642 (1 a mM), the
release of cytokines at 5 h REOX was reduced between 26% and
45% (p,0.05). These data imply that inhibition of NHE1 activity
also decreases cytokine release from reactive astrocytes.
To rule out that possible contaminating microglia in the
astrocyte culture contribute to the cytokine release in the study, we
measured the cytokine release from LME-treated astrocyte
cultures which were depleted of microglia (Figure 5). In the
microglia-depleted astrocyte cultures, similar levels of cytokine
release were detected from the astrocyte cultures at 5 h REOX.
Figure 3. Changes of [Na+]i and [Ca
2+]i in hippocampal
astrocytes following OGD/REOX. A. [Na+]i in hippocampal astrocyte
cultures was determined with Sodium Green dye at 2 h normoxia or
after 2 h OGD followed by 0, 1, 5, or 24 h REOX. HOE 642 (1 mM) was
present during REOX only. Data are mean 6 SEM. The values of ,10
cells from each coverslip/culture were averaged. N of 3 cultures were
for all groups except for normoxia, 0 h REOX, and 24 h REOX+HOE 642
(n = 4) or.5 h REOX and 24 h REOX (n= 5). *p,0.05 vs. normoxic control,
# p,0.05 vs. corresponding untreated. B. [Ca2+]i in hippocampal
astrocytes following OGD/REOX. [Ca2+]i in hippocampal astrocyte
cultures was determined at 2 h normoxia or after 2 h OGD followed
by 0, 1, 3, or 5 h REOX using fura-2 AM. HOE 642 (1 mM) or SEA 0400
(1 mM) was present during REOX only. The values of ,10 cells from
each coverslip/culture were averaged. Data are expressed as mean 6
SEM. N of 4 cultures were for normoxia and the rest of other conditions
were n of 3 cultures. *p,0.05 vs. normoxic control, # p,0.05 vs.
corresponding untreated.
doi:10.1371/journal.pone.0084294.g003
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Inhibition of NHE1 significantly reduced the cytokine release.
Taken together, these findings firmly suggest that activation of
NHE1 during 5 h REOX not only triggered glutamate release,
but also increased pro-inflammatory cytokine release in hippo-
campal astrocytes.
Minimal Cell Death of Reactive Astrocytes After OGD/
REOX
We further investigated the impact of the above cellular changes
on astrocyte viability. Under normoxic conditions, astrocytes in
the culture retained the calcein dye with minimum PI staining
(Figure 6A a, a`). The cell death rate was 0.8360.14% (Figure 6
B). When astrocytes were subjected to OGD, followed with either
5 h REOX (Figure 6 A b, b`) or 24 REOX (Figure 6 A d, d`),
the cell death rates remained at ,1% (Figure 6 B). Inhibition of
NHE1 with HOE 642 did not change the cell death in astrocytes
(Figure 6 A c, c` and Figure 6 A e,e`). These data suggest that
reactive astrocytes were resistant to ischemia-mediated cell death.
Discussion
Role of NHE1 in Regulation of pHi in Hippocampal
Astrocytes Following OGD/REOX
In this study, the resting pHi in murine hippocampal astrocytes
was 6.9460.02 under HCO3
–free normoxic conditions. This is
consistent with reports of resting pHi values under HCO3
2 -free
conditions that range from 6.88 to 7.05 in rat hippocampal
astrocytes [17–19]. Bevensee et al. (1997) reported that under
nominally HCO3
2 free conditions, 88% of the prepulse-induced
pHi recovery rate in rat hippocampal cultures was sensitive to
0.9 mM amiloride [20]. In addition, when amiloride was applied
under steady state conditions, there was a decrease in pHi. Similar
results were reported with 1 mM amiloride [21]. In the current
study, using the potent NHE1 inhibitor HOE 642 (1 mM), we
observed 86% blockade of the pHi recovery rates in hippocampal
astrocytes. Thus, in the absence of HCO3
2, NHE1 plays a
dominant role in pHi regulation in hippocampal astrocytes.
Indeed, mRNA expression for NHE1 in brain is ten-times the
level of other NHE isoforms [22]. NHE2 and NHE3 transcripts
were only present in the granule and Purkinje cells of the
cerebellum. NHE4 protein expression is undetectable in hippo-
campal astrocyte cultures [18]. On the other hand, there is weak
expression of NHE3 protein in mouse hippocampus [23]. The
other plasma membrane NHE5 has been characterized as largely
insensitive to amiloride, and is restricted to the cell bodies of
neurons of the hippocampus [24,25]. Taken together, NHE1 is the
primary NHE isoform in regulation of pHi in hippocampal
astrocytes and the contribution of other NHE isoforms is minimal.
The residual NHE1-independent pHi regulation likely results from
activity of a H+ pump [21] or lactate-H+ co-transport [26].
In the current study, 2 h of OGD led to an increase in NHE1
expression in hippocampal astrocytes that was sustained during
5 h REOX. The underlying mechanisms for this upregulation are
unknown. Previously, we observed an increase in HIF-1a
expression in cortical neurons that preceded the up-regulation of
NHE1 protein after OGD/REOX [27]. Given that the promoter
region of NHE1 gene contains a candidate-binding site for HIF-1a
Figure 4. Glutamate and pro-inflammatory cytokine release from hippocampal astrocytes following OGD/REOX. A. Glutamate release
in hippocampal astrocyte cultures was determined at 2 h normoxia or after 2 h OGD followed by 0, 1, 5, or 24 h REOX. In drug treated experiments,
HOE 642 (1 mM) or TBOA (100 mM) was present during REOX only. Data are mean 6 SEM. N of 4 cultures were for all groups except for normoxia
(n = 5). *p,0.05 vs. normoxic control, # p,0.05 vs. corresponding untreated. ND: not detectable. Inset: The reversal potential for the glutamate
transport was plotted as a function of [Na+]i. The known values for [Na]o, [H]o, [H]i and [K]o at baselines were used along with an assumed value for
[Glu]o of 0.01 mM, [Glu]i of 5 mM and [K]i of 70 mM. B–D. Release of innate immune cytokines in the culture medium of hippocampal astrocytes. HOE
642 (1 mM) was present during normoxia or REOX treatment. IL-1b (B) IL-6 (C), or TNF-a (D) were normalized to cell lysate protein and expressed as
pg/mg protein. Data are mean 6 SEM (n= 3). ND: not detectable. *p,0.05 vs. normoxic control. # p,0.05 vs. corresponding untreated.
doi:10.1371/journal.pone.0084294.g004
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it is likely that HIF-1a plays a role in hypoxia-induced up-
regulation of NHE1 [28].
NHE1 Activation and Glutamate Release from
Hippocampal Astrocytes After OGD/REOX
Rapid removal of glutamate from extracellular space is
primarily a function of astrocytes and is critical for neuronal
physiology and survival. However, under both physiological and
pathophysiological conditions, astrocytes will release glutamate
through a number of mechanisms including swelling-induced
anion channel opening and ionotropic purinergic receptors, Ca2+-
dependent exocytosis, or glutamate exchange via the cysteine-
glutamate antiporter [29]. However, reversal of Na+-dependent
glutamate transporters has been implicated as a major factor
responsible for excessive glutamate release during ischemia that
leads to a cytotoxic cascade and neuronal death [29]. To date, five
different high-affinity glutamate transporters have been cloned:
GLAST, GLT, EAAC, EAAT4 and EAAT5. However, GLT-1
and GLAST are together responsible for most of the glutamate
uptake activity in most regions of the mammalian CNS and are
only found in astroglia in normal mature brains [30]. This
highlights the importance of astroglia in extracellular glutamate
removal [30]. Developmentally, GLAST expression dominates
early in astrocytes but is overtaken by GLT-1 expression with
maturity. In primary rat astrocyte cultures, it has been shown that
only GLAST is expressed unless the cells are treated with
dBcAMP or grown in the presence of neurons [31]. Under these
conditions, GLAST expression was increased by two-three fold
and GLT-1 expression was robustly induced. Similar results have
been shown in primary hippocampal astrocytes grown with
neurons [32]. Thus, in our differentiated cultures, we would
expect both isoforms are involved (data not shown).
In vivo, it has been estimated that glutamate uptake is made
against an extracellular to intracellular gradient of , 1:2500 [33].
To accomplish this, glutamate transport is coupled to the transport
of Na+ and K+ down their respective concentration gradients. In
addition, because of the stoichiometry of three Na+ to one H+ and
the counter-transport of one K+ for each glutamate anion moved
into the cell, there is a net movement of two positive charges and
the plasma membrane potential likely contributes to the driving
force [34,35]. Therefore, changes of Na+ and H+ homeostasis can
alter the driving force of glutamate uptake via EAATs and trigger
its release from astrocytes.
In this study, we detected concurrent intracellular Na+ overload
and glutamate release from hippocampal astrocytes after 5 h of
REOX following 2 h of OGD. This release was largely inhibited
by TBOA, a nontransportable inhibitor of GLAST and GLT-1,
suggesting that the glutamate release was the result of glutamate
transport reversal. Interestingly, in the presence of HOE 642, the
calculated reversal potential of the glutamate transported at 5 h
REOX was 257.94 mV (vs. 278.2 mV at OGD/REOX),
suggesting that inhibition of NHE1 and subsequent reduction of
Na+ overload would help to prevent EEATs-mediated glutamate
release from astrocytes following ischemia. These findings are
consistent with other previous reports. Investigators have reported
neuroprotection with the use of glutamate transporter inhibitors
during bilateral carotid occlusion/hypotension in rats [36],
neonatal hypoxic ischemia [37], and in rat dorsal column slices
exposed to anoxia [38]. EEAT reversal in astrocytes has been
demonstrated in vitro by raising extracellular K+ [39,40], OGD
perfusion [41], or metabolic blockade using idoacetate/KCN or
NaF/azide [42,43].
Xie et al measured changes in astrocytic plasma membrane
potential when hippocampal slices were exposed to OGD [44].
They found that 30 min of OGD caused membrane potential to
depolarize by , 25 mV, but when the slice was reoxygenated
there was a transient hyperpolarization of the plasma membrane
by 9 mV before returning to the pre-OGD potential. This
hyperpolarization was attributed to enhanced Na+/K+-ATPase
activity because it could be blocked by the application of ouabain
[45]. We have previously reported that 2 h OGD in cultured
cortical astrocytes results in an , 30% decrease in ATP content
[13]. Thus, while OGD results in a partial loss of plasma
membrane potential in hippocampal astrocytes, Na+/K+-ATPase
activity appears to still be functional. Therefore, increased Na+
influx in hippocampal astrocytes after OGD/REOX, rather than
altered Na+ pump function or membrane depolarization, seem to
drive reversal of EAATs in hippocampal astrocytes.
NHE1 Activation and Cytokine Release from Reactive
Astrocytes After OGD/REOX
It is well recognized that the activation of astrocytes is
accompanied by increased production of potentially neurotoxic
factors, including cytokines [46] Both astrocytes and microglia
have been shown to release a myriad of pro- and anti-
Figure 5. Pro-inflammatory cytokine release from LME-treated
hippocampal astrocyte cultures following OGD/REOX. Release
of innate immune cytokines was detected in the culture medium of
hippocampal astrocytes at 2 h normoxia control or 2 h OGD followed
by 5 h REOX. HOE 642 (1 mM) was present during normoxia or REOX
treatment (with 5 mM LME). IL-1b (A), IL-6 (B), TNF-a (C). Cytokine
content was normalized to cell lysate protein and expressed as pg/mg
protein. Data are mean 6 SEM (n= 3). *p,0.05 vs. normoxic control. #
p,0.05 vs. corresponding untreated, ND: not detectable.
doi:10.1371/journal.pone.0084294.g005
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inflammatory cytokines, including interleukins, interferons and
tumor necrosis factors, as well as chemokines [47]. Findings from
Lau and Yu (2001) suggest that astrocytes respond to pathophys-
iological conditions by releasing cytokines [48]. It has been
proposed that a central role of astrocytes in regulating neuroin-
flammation in the CNS is via the NF-kB pathway [49,50]. Here
we observed that 5 h REOX significantly increased the secretion
of several inflammatory cytokines (IL-1b, IL-6 and TNF-a) in
astrocytes. Interestingly, the release was ablated by the inhibition
of NHE1. Increases in intracellular Na+ and Ca2+ levels in
hippocampal astrocytes after OGD/REOX may be the trigger
behind astrocytic activation and subsequent cytokine release.
Collectively, these results suggest that astrocytes-induced cytokines
release following in vitro HI may be regulated by NHE1 and
changes of Na+ and Ca2+.
In a recent interesting study, Kim et al. (2011) demonstrated a
role for intracellular Ca2+ as a signal pathway for astrocyte
mediated cytokines release [51]. The authors reported that
cytokines produced by primary astrocytes and bone marrow-
derived mast cell co-cultures are mainly induced by signaling via
Ca2+/PKCs/MAP kinases/NF-kB/STAT1727 pathways and the
cytokines produced subsequently re-activate astrocytes via Jak/
STAT1701, which then release more cytokines thereby contribut-
ing to the exacerbation of experimental allergic encephalomyelitis
in mice. The authors reported that activation of astrocytes is
usually manifested as a rise of intracellular Ca2+ level due to
Figure 6. Minimal cell death of reactive astrocytes after OGD/REOX. Hippocampal astrocytes were grown on 24 well culture dishes and
subjected to 2 h OGD followed by 5 h or 24 h REOX. HOE 642 (1 mM) was present only during REOX. At the end of REOX, cells were loaded with
calcein-AM (green) and PI (red). A. Representative images of live (calcein positive) and dead (PI positive) cells of normoxia (a, a`), 5 h REOX (b, b`), 5 h
REOX+HOE 642 (c, c`), 24 REOX (d, d`) or 24 REOX+HOE 642 (e, e`). B. Summary of reactive astrocyte death from six wells from each experimental
condition. Data are mean 6 SEM. n = 6.
doi:10.1371/journal.pone.0084294.g006
Figure 7. Proposed role of NHE1 in reactive hippocampal astrocytes following OGD/REOX. In resting astrocytes under normoxic
conditions, NHE1 and NCX function in removal of intracellular H+ and Ca2+. Glutamate transporters (EAAT) uptake glutamate (Glu) into astrocytes to
maintain its low extracellular content. In response to OGD/REOX, up-regulation of NHE1 promotes sustained H+ efflux in exchange of Na+ influx in
reactive astrocytes. This Na+ overload triggers the reversal mode operation of NCX and Ca2+ influx. The intracellular Ca2+ rise serves as a signal to
release innate cytokines, while elevation of Na+i leads to Glu release either via decreased uptake of Glu through EEAT or their reversed operation.
doi:10.1371/journal.pone.0084294.g007
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release of Ca2+ from internal stores as well as Ca2+ uptake from the
extracellular space. This suggests that NHE1 may have an
important role in astrocyte mediated inflammatory responses
following HI. Recently, we have shown that NHE1 is required for
microglial activation and proinflammatory responses after ische-
mia. In cultured microglia, activation by several stimuli depends
on NHE1 mediated H+ homeostasis and inhibition of NHE1 with
HOE 642 also reduced the production of superoxide anions as
well as proinflammatory cytokines IL-1b, IL-6, and TNF-a
induced by LPS or in vitro ischemia [52]. These results were
supported by evidence from in vivo ischemia studies where
activation of microglia leading to proinflammatory cytokine
production and phagocytosis is significantly reduced with NHE1
inhibition or genetic knockdown [53].
In summary, NHE1 protein expression was up-regulated in
reactive hippocampal astrocytes after in vitro ischemia (Figure 7).
Concurrently, NHE1 activity is elevated, [Na+i] and [Ca
2+
i]
increased, leading to cytokine and glutamate release from
hippocampal astrocytes but did not cause cell death. Interestingly,
although inhibition of NHE1 activity did not change reactive
astrocyte death, it significantly reduced the release of glutamate
and cytokines. Therefore, we concluded that over-stimulation of
NHE1 promotes gliotransmitter and cytokine release from reactive
astrocytes, which can subsequently contribute to hippocampal
neuronal damage under hypoxic and ischemic conditions.
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